Motley Fool Premium
  1. Stocks
    2. /
  2. AstraZeneca PLC (LSE: AZN)
    3. /

LSE:AZN (AstraZeneca PLC)

About AZN

AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
Financial Market Data copyright © 2026 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

AstraZeneca PLC (LSE: AZN) Latest News

Investing Articles

3 Neil Woodford Plays On Ageing Populations: AstraZeneca plc, Smith & Nephew plc And Capita PLC

| G A Chester

AstraZeneca plc (LON:AZN), Smith & Nephew plc (LON:SN) and Capita PLC (LON:CPI) could super-charge your portfolio.

Read more »

Investing Articles

Is AstraZeneca plc A Safe Dividend Investment?

| Kevin Godbold

Not all dividends are as safe as they seem. What about AstraZeneca plc (LON: AZN)?

Read more »

Investing Articles

Is Now The Time To Buy Shire PLC And AstraZeneca plc?

| Rupert Hargreaves

Should you buy Shire PLC (LON: SHP) and AstraZeneca plc (LON: AZN) after recent declines.

Read more »

Investing Articles

Can AstraZeneca plc Help You To Retire Rich?

| Peter Stephens

Dreaming of wealth in retirement? Here’s how AstraZeneca plc (LON: AZN) could help you get there.

Read more »

Investing Articles

Why Shire PLC And AstraZeneca plc Are Falling Today

| Roland Head

Investors in Shire PLC (LON:SHP) and AstraZeneca plc (LON:AZN) are selling in response to new US tax rules.

Read more »

Investing Articles

5 Stunning Reasons Why GlaxoSmithKline plc And AstraZeneca plc Could Shoot The Lights Out!

| Peter Stephens

Here’s why GlaxoSmithKline plc (LON: GSK) and AstraZeneca plc (LON: AZN) could boost your portfolio.

Read more »

Investing Articles

Turn £10k Into £30k With AstraZeneca plc

| Alan Oscroft

AstraZeneca plc (LON: AZN) would have trebled your money in 10 years.

Read more »

Investing Articles

Are AstraZeneca plc & GlaxoSmithKline plc A Sound Investment Right Now?

| Alessandro Pasetti

AstraZeneca plc (LON:AZN) and GlaxoSmithKline plc (LON:GSK) could outperform companies operating in more troubled sectors, and for different reasons, argues…

Read more »

Investing Articles

Why AstraZeneca plc Should Beat The FTSE 100 This Year

| Alan Oscroft

AstraZeneca plc (LON: AZN) is powering ahead in 2014.

Read more »

Investing Articles

AstraZeneca plc Could Be Worth 5100p!

| Peter Stephens

Shares in AstraZeneca plc (LON: AZN) have huge potential and could deliver a total return of 20%+. Here’s why.

Read more »

Investing Articles

A Scottish ‘Yes’ Can Boost ARM Holdings Plc, AstraZeneca plc, BHP Billiton plc, Diageo plc & GlaxoSmithKline plc

| Harvey Jones

ARM Holdings Plc (LON:ARM), AstraZeneca plc (LON:AZN), BHP Billiton plc (LON:BLT), Diageo plc (LON:DGE) and GlaxoSmithKline plc (LON:GSK) shareholders may…

Read more »

Investing Articles

Is GlaxoSmithKline plc’s Opportunity AstraZeneca plc’s Threat?

| Daniel Mark Harrison

Both GlaxoSmithKline plc (LON:GSK) and AstraZeneca plc (LON:AZN) are major competitors in the pharmaceutical space.

Read more »